The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on aIIbβ3, αvβ3, and α5β3 integrins

被引:63
作者
Calvete, JJ
Fox, JW
Agelan, A
Niewiarowski, S
Marcinkiewicz, C [1 ]
机构
[1] Temple Univ, Sch Med, Dept Microbiol, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA
[2] CSIC, Inst Biomed Virginia, Valencia 46010, Spain
[3] Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA
关键词
D O I
10.1021/bi015627o
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two highly homologous dimeric disintegrins, CC5 and CC8, have been isolated from the venom of the North African sand viper Cerastes cerastes. CC5 is a homodimer containing an RGD motif in its subunits. CC8 is a heterodimer. The CC8A and CC8B subunits contain RGD and WGD tripeptide sequence in their respective integrin-binding loops. Both CC5 and CC8 inhibited platelet aggregation and the adhesion of cells expressing integrins alphaIIbeta3, alphavbeta3, and alpha5beta1 to appropriate ligands. However, the inhibitory activity of CC8 was at least I order of magnitude higher than that of CC5. Enhanced activity of CC8 over CC5 was also observed in the induction of LIBS epitopes on beta1 and beta3 integrins. Synthetic peptides in which the arginyl residue of the RGD motif had been replaced with tryptophans exhibited increased inhibitory activity toward integrins alpha5beta1, alphaIIbbeta3, and alphavbeta3. Moreover, alanine substitution of the aspartic acid of the WGD motif of these peptides decreased their inhibitory ability, whereas the same substitution in the RGD sequence almost completely abolished the activity of the peptides. We conclude that the WGD motif enhances the inhibitory activity of disintegrins toward alphaIIbbeta3, alphavbeta3, and alpha5beta1 integrins.
引用
收藏
页码:2014 / 2021
页数:8
相关论文
共 38 条
[11]  
GAN ZR, 1988, J BIOL CHEM, V263, P19827
[12]   Amino acid structure and characterization of a heterodimeric disintegrin from Vipera lebetina venom [J].
Gasmi, A ;
Srairi, N ;
Guermazi, S ;
Dkhil, H ;
Karoui, H ;
El Ayeb, M .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2001, 1547 (01) :51-56
[13]   β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival [J].
Hodivala-Dilke, KM ;
McHugh, KP ;
Tsakiris, DA ;
Rayburn, H ;
Crowley, D ;
Ullman-Culleré, M ;
Ross, FP ;
Coller, BS ;
Teitelbaum, S ;
Hynes, RO .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :229-238
[14]   INTEGRINS - VERSATILITY, MODULATION, AND SIGNALING IN CELL-ADHESION [J].
HYNES, RO .
CELL, 1992, 69 (01) :11-25
[15]   Snake venom metalloproteinases: Structure, function and relationship to the Adams family of proteins [J].
Jia, LG ;
Shimokawa, KI ;
Bjarnason, JB ;
Fox, JW .
TOXICON, 1996, 34 (11-12) :1269-1276
[16]   STRUCTURAL DOMAINS IN VENOM PROTEINS - EVIDENCE THAT METALLOPROTEINASES AND NONENZYMATIC PLATELET-AGGREGATION INHIBITORS (DISINTEGRINS) FROM SNAKE-VENOMS ARE DERIVED BY PROTEOLYSIS FROM A COMMON PRECURSOR [J].
KINI, RM ;
EVANS, HJ .
TOXICON, 1992, 30 (03) :265-293
[17]   MECHANISMS OF DISEASE - PLATELET GLYCOPROTEIN IIB/IIIA RECEPTORS IN CARDIOVASCULAR MEDICINE [J].
LEFKOVITS, J ;
PLOW, EF ;
TOPOL, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (23) :1553-1559
[18]   Structural and functional characterization of EMF10, a heterodimeric disintegrin from Eristocophis macmahoni venom that selectively inhibits α5β1 integrin [J].
Marcinkiewicz, C ;
Calvete, JJ ;
Vijay-Kumar, S ;
Marcinkiewicz, MM ;
Raida, M ;
Schick, P ;
Lobb, PR ;
Niewiarowski, S .
BIOCHEMISTRY, 1999, 38 (40) :13302-13309
[19]   EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits α4 and α5 integrins in an RGD-independent manner [J].
Marcinkiewicz, C ;
Calvete, JJ ;
Marcinkiewicz, MM ;
Raida, M ;
Vijay-Kumar, S ;
Huang, ZW ;
Lobb, RR ;
Niewiarowski, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12468-12473
[20]   Significance of RGD loop and C-terminal domain of echistatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins and expression of ligand-induced binding site [J].
Marcinkiewicz, C ;
VijayKumar, S ;
McLane, MA ;
Niewiarowski, S .
BLOOD, 1997, 90 (04) :1565-1575